REVERSIBLE KOVALENTE PYRROLO- ELLER PYRAZOLOPYRIMIDINER, DER ER NYTTIGE TIL BEHANDLING AF CANCER OG AUTOIMMUNSYGDOMME
Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | Danish |
| Published |
02.03.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases. |
|---|---|
| AbstractList | Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases. |
| Author | GOLDSTEIN, David Michael BERNER, Bret |
| Author_xml | – fullname: GOLDSTEIN, David Michael – fullname: BERNER, Bret |
| BookMark | eNqNis0KgkAURl3Uor93uO1zUVHkcnSuenF-YhwF24jEtAoVrPdvgh4g-OBw-M4ymPVD7xbB22CNpqRYIBS6ZgKVRbg2xmihQ0Ah0HyV3bx7kiROCs0OuD_8VGMtZQiWBMSYM8UFqQxYCglTiQ-0l8pqkrJSZZNxLSWug_mje05u8-Mq2KZokzx049C6aezurnevlheHy3l_iiJrj8d_mg-4Lzve |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | DK2861599TT3 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_DK2861599TT33 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 15:17:14 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Danish |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_DK2861599TT33 |
| Notes | Application Number: DK20130731218T |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200302&DB=EPODOC&CC=DK&NR=2861599T3 |
| ParticipantIDs | epo_espacenet_DK2861599TT3 |
| PublicationCentury | 2000 |
| PublicationDate | 20200302 |
| PublicationDateYYYYMMDD | 2020-03-02 |
| PublicationDate_xml | – month: 03 year: 2020 text: 20200302 day: 02 |
| PublicationDecade | 2020 |
| PublicationYear | 2020 |
| RelatedCompanies | Principia Biopharma Inc |
| RelatedCompanies_xml | – name: Principia Biopharma Inc |
| Score | 3.2515547 |
| Snippet | Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production and use of these... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | REVERSIBLE KOVALENTE PYRROLO- ELLER PYRAZOLOPYRIMIDINER, DER ER NYTTIGE TIL BEHANDLING AF CANCER OG AUTOIMMUNSYGDOMME |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200302&DB=EPODOC&locale=&CC=DK&NR=2861599T3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3bSsMwNMwp6ptOReeFCNIni10v6_pQpG3Sra6XkWVj82W0XQt72Ybr8Pc9LZv6ohBITg6E5MC5JDkXhJ6kVJrHatoWUz1PRTXXOmLSyiQx1vI0M1SwoeUy3jkI272R-jbRJjW02MfCVHlCP6vkiMBRKfB7Ucnr9c8jFql8KzcvyQKmVq8uN4mwux2XnlaSLBDbpIOIRI7gOCbpCyEz5Q6obsPgygE6BCtaL5mBju0yKGX9W6O4Z-hoAIsti3NUm8cNdOLsC6810HGw---G4Y71Nhdoy-iYsqFn-xT3o7Hl05BTPJgyFvmRiKnvU1aC1jvA0INQIl5I2TMmgIAWTjn3uhRzz8c27Vkh8b2wiy0XO2WBGoYjAEY88oJgFA6nXRIFAb1Ejy7lTk-E_c--aTUj_f1JuaJcofpytcyuEe7kUq61cgUuHDIYSLqRpGUyRENPWvOWmsQ3qPn3Os3_kLfotKR75ZYl36F68bHN7kFPF8lDReEvBYaPCA |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8IwsEE04puiRvGrJmZPLm5jY-xhMdvasbkvMgoBX8g2toQXIALx73tbQH3RpEl7vaTpR-6rvbsi9CRkwiyRsw6fqUXGy4XS5VMxF_hEKbJck0GHlsp45yDsOEP5bayMa2i-j4Wp8oR-VskRgaIyoPdNxa9XP5dYpPKtXL-kc-havtpMJ9zOOi49rQSJI6ZO-xGJLM6ydOJxYaxLXRDdmsbaB-gQNGy1JAY6MsuglNVviWKfoqM-DLbYnKHaLGmihrX_eK2JjoPdezc0d6S3PkfbmI5oPHBNn2IvGhk-DRnF_UkcR37EY-r7NC5B4x1gqIEpETek8TMmgIASThhzexQz18cmdYyQ-G7Yw4aNrfKDmhhHAAxZ5AbBMBxMeiQKAnqBHm3KLIeH-U-_92pKvP1KWbt9ieqL5SK_QrhbCIUiFm0wOCRQkFQtzcpkiJqaijNRTpNr1Pp7nNZ_yAfUcFjgT2HK3g06Kc-gctGSblF987HN70Bmb9L7are_AOiUkfs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=REVERSIBLE+KOVALENTE+PYRROLO-+ELLER+PYRAZOLOPYRIMIDINER%2C+DER+ER+NYTTIGE+TIL+BEHANDLING+AF+CANCER+OG+AUTOIMMUNSYGDOMME&rft.inventor=GOLDSTEIN%2C+David+Michael&rft.inventor=BERNER%2C+Bret&rft.date=2020-03-02&rft.externalDBID=T3&rft.externalDocID=DK2861599TT3 |